Loading...
Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy
Melanoma is responsible for most skin cancer-related deaths and is one of the most common cancers diagnosed in young adults. In melanoma, tumors can become established by activation of the negative regulator of cytotoxic T lymphocytes (CTLs), CTL antigen-4 (CTLA-4). Ipilimumab blocks the interaction...
Saved in:
| Published in: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Taylor & Francis
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485758/ https://ncbi.nlm.nih.gov/pubmed/26155423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1008842 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|